Shopping Cart 0
Cart Subtotal
AED 0

Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Athersys Inc (ATHX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Athersys Inc (Athersys) is a biotechnology company that discovers and develops novel and proprietary best-in-class therapies in the field of regenerative medicine. Its lead platform, MultiStem, is a patented stem cell product, developed for treating multiple disease indications such as cardiovascular diseases, inflammatory and immune disorders, neurological conditions and others. Its MultiStem program includes product candidates at various levels of clinical trials for treating acute myocardial infarction, bone marrow/hematopoietic stem cell transplantation, ischemic stroke and autoimmune disease. Athersys is headquartered in Cleveland, Ohio, the US.

Athersys Inc Key Recent Developments

May 08,2019: Athersys reports first quarter 2019 results

Apr 01,2019: Athersys to participate in two upcoming healthcare conferences

Mar 14,2019: Athersys announces financial results for fourth quarter and full year 2018

Aug 07,2018: Athersys reports second quarter 2018 results

May 10,2018: Athersys Reports First Quarter 2018 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Athersys Inc-Key Facts

Athersys Inc-Key Employees

Athersys Inc-Key Employee Biographies

Athersys Inc-Major Products and Services

Athersys Inc-History

Athersys Inc-Company Statement

Athersys Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Athersys Inc-Business Description

Athersys Inc-Corporate Strategy

Athersys Inc-SWOT Analysis

SWOT Analysis-Overview

Athersys Inc-Strengths

Athersys Inc-Weaknesses

Athersys Inc-Opportunities

Athersys Inc-Threats

Athersys Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Athersys Inc, Recent Deals Summary

Section 5-Company's Recent Developments

May 08, 2019: Athersys reports first quarter 2019 results

Apr 01, 2019: Athersys to participate in two upcoming healthcare conferences

Mar 14, 2019: Athersys announces financial results for fourth quarter and full year 2018

Aug 07, 2018: Athersys reports second quarter 2018 results

May 10, 2018: Athersys Reports First Quarter 2018 Results

Mar 13, 2018: Athersys Reports Financial Results for Fourth Quarter, Full Year 2017

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Athersys Inc, Performance Chart (2014-2018)

Athersys Inc, Ratio Charts

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Athersys Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Athersys Inc, Key Facts

Athersys Inc, Key Employees

Athersys Inc, Key Employee Biographies

Athersys Inc, Major Products and Services

Athersys Inc, History

Athersys Inc, Subsidiaries

Athersys Inc, Key Competitors

Athersys Inc, Ratios based on current share price

Athersys Inc, Annual Ratios

Athersys Inc, Annual Ratios (Cont...1)

Athersys Inc, Interim Ratios

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Athersys Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Athersys Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Vericel Corp

Pfizer Inc

Mesoblast Ltd

Cytori Therapeutics Inc

Cryo-Cell International Inc

Celgene Corp

Astellas Institute for Regenerative Medicine

Arena Pharmaceuticals Inc

Company Profile

Company Profile Title

Athersys Inc (ATHX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Athersys Inc (Athersys) is a biotechnology company that discovers and develops novel and proprietary best-in-class therapies in the field of regenerative medicine. Its lead platform, MultiStem, is a patented stem cell product, developed for treating multiple disease indications such as cardiovascular diseases, inflammatory and immune disorders, neurological conditions and others. Its MultiStem program includes product candidates at various levels of clinical trials for treating acute myocardial infarction, bone marrow/hematopoietic stem cell transplantation, ischemic stroke and autoimmune disease. Athersys is headquartered in Cleveland, Ohio, the US.

Athersys Inc Key Recent Developments

May 08,2019: Athersys reports first quarter 2019 results

Apr 01,2019: Athersys to participate in two upcoming healthcare conferences

Mar 14,2019: Athersys announces financial results for fourth quarter and full year 2018

Aug 07,2018: Athersys reports second quarter 2018 results

May 10,2018: Athersys Reports First Quarter 2018 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Athersys Inc-Key Facts

Athersys Inc-Key Employees

Athersys Inc-Key Employee Biographies

Athersys Inc-Major Products and Services

Athersys Inc-History

Athersys Inc-Company Statement

Athersys Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Athersys Inc-Business Description

Athersys Inc-Corporate Strategy

Athersys Inc-SWOT Analysis

SWOT Analysis-Overview

Athersys Inc-Strengths

Athersys Inc-Weaknesses

Athersys Inc-Opportunities

Athersys Inc-Threats

Athersys Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Athersys Inc, Recent Deals Summary

Section 5-Company's Recent Developments

May 08, 2019: Athersys reports first quarter 2019 results

Apr 01, 2019: Athersys to participate in two upcoming healthcare conferences

Mar 14, 2019: Athersys announces financial results for fourth quarter and full year 2018

Aug 07, 2018: Athersys reports second quarter 2018 results

May 10, 2018: Athersys Reports First Quarter 2018 Results

Mar 13, 2018: Athersys Reports Financial Results for Fourth Quarter, Full Year 2017

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Athersys Inc, Performance Chart (2014-2018)

Athersys Inc, Ratio Charts

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Athersys Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Athersys Inc, Key Facts

Athersys Inc, Key Employees

Athersys Inc, Key Employee Biographies

Athersys Inc, Major Products and Services

Athersys Inc, History

Athersys Inc, Subsidiaries

Athersys Inc, Key Competitors

Athersys Inc, Ratios based on current share price

Athersys Inc, Annual Ratios

Athersys Inc, Annual Ratios (Cont...1)

Athersys Inc, Interim Ratios

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Athersys Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Athersys Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Vericel Corp

Pfizer Inc

Mesoblast Ltd

Cytori Therapeutics Inc

Cryo-Cell International Inc

Celgene Corp

Astellas Institute for Regenerative Medicine

Arena Pharmaceuticals Inc